Stockreport

Cancer Research Highlight: Seattle Genetics Moves The Chains In T-Cell Lymphoma [Seeking Alpha]

Seagen Inc.  (SGEN) 
Last seagen inc. earnings: 4/30 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.seattlegenetics.com
PDF Summary Seattle Genetics has worked hard to move their scope of focus out of only Hodgkin lymphoma. New clinical trial results suggest that they will move immin [Read more]